Founded in 2004 by CEO James J. Chen, Ph.D., Agno Pharmaceuticals has grown into a US-headquartered global CDMO with about 500 employees. The company supports pharmaceutical and biotech clients from early development through commercial production, with a particular reputation for handling complex sterile drug products and challenging poorly soluble compounds.
ISO 13485:2016
Agno PharmaceuticalsEstablished in 2004 by CEO and founder James J. Chen, Agno Pharmaceuticals is a US-headquartered global CDMO with roughly 500 employees. The company is known for helping pharmaceutical and biotech clients move challenging drug programs from development into clinical and commercial production, with particular depth in sterile products and long-acting implants.BETHLEHEM, PA
Pharmaceutical Manufacturing Research Services, Inc. (PMRS)Founded by Edwin R. Thompson in 1994, privately held PMRS develops and contract-manufactures pharmaceutical products from clinical supply through commercial production, with analytical and quality support under one roof. The Horsham company has grown from six employees to about 30 and has completed more than 550 projects, supporting four NDA-approved commercial products, an internationally approved product, and developmental drugs. Its 130,000-square-foot custom facility and hands-on, cross-functional staff reflect a model in which every team member is involved in each project.HORSHAM, PA
US Specialty Formulations LLCFounded in 2013, US Specialty Formulations is an Allentown cGMP manufacturer built by scientists with decades of pharmaceutical development experience. The company is known for boutique, small-batch support for drug developers, helping move clinical programs from formulation work into regulated production. Its facility is especially suited to sterile injectable manufacturing for pharmaceutical and biotech partners.BETHLEHEM, PA
PCI Pharma ServicesPCI Pharma Services is a global contract development and manufacturing organization supporting pharmaceutical and biopharmaceutical clients from early development through commercialization. It operates 38 global GMP facilities and provides sterile and non-sterile drug manufacturing alongside clinical-trial and commercial packaging services. Its integrated capabilities include sterile fill-finish, lyophilization, and assembly of drug-device combination products.PHILADELPHIA, PA